Pacira to Report Second Quarter 2024 Financial Results on Tuesday July 30, 2024
23 July 2024 - 10:00PM
Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will
report its second quarter financial results after the close of the
U.S. markets on Tuesday July 30, 2024. Following the release, the
company will host a live conference call and webcast at 4:30 p.m.
ET.
For listeners who wish to participate in the question and answer
session via telephone, please pre-register here. All registrants
will receive dial-in information and a PIN allowing them to access
the live call. In addition, a live audio of the conference call
will be available as a webcast. Interested parties can access the
event through the “Events” page on the Pacira website at
investor.pacira.com. For those unable to participate in the live
call, a replay of the webcast will be available on the Pacira
website for approximately two weeks following the call.
About Pacira
Pacira BioSciences, Inc. (Nasdaq: PCRX) is committed to
providing a non-opioid option to as many patients as possible to
redefine the role of opioids as rescue therapy only. The company is
also developing innovative interventions to address debilitating
conditions involving the sympathetic nervous system, such as
cardiac electrical storm, chronic pain, and spasticity. Pacira has
three commercial-stage non-opioid treatments: EXPAREL® (bupivacaine
liposome injectable suspension), a long-acting, local analgesia
currently approved for postsurgical pain management; ZILRETTA®
(triamcinolone acetonide extended-release injectable suspension),
an extended-release, intra-articular, injection indicated for the
management of osteoarthritis knee pain; and ioveraº®, a novel,
handheld device for delivering immediate, long-acting, drug-free
pain control using precise, controlled doses of cold temperature to
a targeted nerve. To learn more about Pacira, including the
corporate mission to reduce overreliance on opioids, visit
www.pacira.com.
Investor Contact:
Pacira BioSciences, Inc.
Christian Pedetti, (973) 254-4387
Christian.Pedetti@pacira.com
Pacira BioSciences (NASDAQ:PCRX)
Historical Stock Chart
From Sep 2024 to Oct 2024
Pacira BioSciences (NASDAQ:PCRX)
Historical Stock Chart
From Oct 2023 to Oct 2024